21 employees
Engrail Therapeutics is a developer of medicines to transform the lives of patients with life-limiting diseases of the nervous system.
2019
$32M
from 2 investors over 2 rounds
Engrail Therapeutics raised $32M on August 3, 2021
Investors: Nan Fung Life Sciences
Engrail Therapeutics raised $32M on June 18, 2020